Endra Life Sciences Inc (NDRA) Technical Analysis
$4.59
Market is closed - opens 7 PM, 06 Apr 2026
Insights
- Endra Life Sciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Endra Life Sciences stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Endra Life Sciences stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Endra Life Sciences stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 66.95 | Sell |
Stochastic | 83.8, 82.31 | Neutral |
Ultimate Oscillator | 71.62 | Sell |
Stochastic Relative Strength Index | 92.05, 91.13 | Neutral |
Moving Average Convergence Divergence | 0.24, 0.08 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.18 | Buy |
20 | 3.77 | Sell |
50 | 3.83 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.28 | Buy |
20 | 4.02 | Buy |
50 | 4.02 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.0 | Buy |
20 | 3.62 | Buy |
50 | 4.22 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.67 | Buy |
20 | 4.28 | Buy |
50 | 3.73 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.85 | Buy |
20 | 4.6 | Buy |
50 | 3.88 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 5.16 |
Resistance L2 | 4.96 |
Resistance L1 | 4.8 |
Pivot Point | 4.6 |
Support L1 | 4.44 |
Support L2 | 4.24 |
Support L3 | 4.08 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.